Anthropic överväger börsnotering redan 2026, enligt FT
Anthropic överväger börsnotering redan 2026, enligt FT
se.investing.comI don’t have live access to up-to-the-minute feeds in this moment, but I can summarize the latest widely reported angles on Anthropic (the Claude creator) and its stock-market/performance context based on recent coverage.
Direct answer
- Latest regulatory/market chatter points to potential public listing activity for Anthropic in the US, with discussions around timing possibly in 2026-2027 and valuations often cited well above initial private rounds. This is based on Financial Times and regional market coverage citing potential IPO preparations, banker engagements, and large private fundraising scenarios.[4][6]
What this means in context
- Valuation and fundraising: After large private rounds (notably a multi-billion Series E in 2025 at a high post-money valuation), investors and market watchers have been discussing whether Anthropic could pursue a public listing at a material premium, with some reports suggesting valuations in the hundreds of billions in private rounds, though IPO timing remains uncertain. This framing appears in multiple outlets and industry chatter.[3][5][4]
- Market impact and sentiment: News about potential stock-market moves tied to Anthropic’s developments has been observed in market commentary and brief news items, sometimes linked to broader AI stock volatility around new product or strategic announcements.[7]
- Corporate updates: Anthropic maintains a newsroom with ongoing product and research updates, reinforcing a steady push in AI safety, alignment, and product capability alongside its commercial expansion.[6]
Illustrative example
- A hypothetical timeline based on reported signals: (1) late 2024–2025 strong private funding and high valuations; (2) 2026–2027 discussions around US IPO readiness and potential advisor engagements; (3) ongoing product releases (Claude, coding tools, etc.) that could influence investor interest ahead of any public listing. This pattern aligns with several media reports, though specifics vary by source.[3][4][6]
Citations
- Anthropic considering a US listing and potential fundraising above USD60B, with banker discussions reported by multiple outlets.[1][2]
- Series E at $61.5B post-money valuation and related product momentum.[3]
- FT and other outlets noting IPO considerations and valuation discussions in 2026.[4]
- Anthropic newsroom for ongoing corporate updates.[6]
If you’d like, I can narrow this to a country-specific IPO timeline, extract exact valuation figures from each cited article, or pull a quick digest of sentiment from recent financial commentary to help decide how to position exposure or research further.